EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Renascience's enterprise value is 円2,923.4 Mil.
Renascience's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円191.3 Mil. Therefore, Renascience's EV-to-Revenue for today is 15.28.
The historical rank and industry rank for Renascience's EV-to-Revenue or its related term are showing as below:
TSE:4889'
s EV-to-Revenue Range Over the Past 10 Years
Min: 12.68 Med: 23.33 Max: 293.52
Current: 15.28
During the past 4 years, the highest EV-to-Revenue of Renascience was 293.52. The lowest was 12.68. And the median was 23.33.
TSE:4889's EV-to-Revenue is ranked worse than 87.06% of 827
companies
in the Medical Devices & Instruments industry
Industry Median: 3.1
vs TSE:4889: 15.28
As of today (2024-06-05), Renascience's stock price is 円363.00.
Renascience's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円15.05. Therefore, Renascience's PS Ratio for today is 24.12.
Renascience EV-to-Revenue Historical Data
The historical data trend for Renascience's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Renascience's EV-to-Revenue
For the Medical Devices subindustry, Renascience's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Renascience's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Renascience's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Renascience's EV-to-Revenue falls into.
Renascience's current Enterprise Value is 円2,923.4 Mil.
Renascience's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円191.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Renascience's share price for today is 円363.00.
Renascience's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円15.05.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Renascience EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Renascience's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Renascience Inc is engaged in the research and development of new medical solutions by utilizing various modalities such as pharmaceuticals, medical devices, artificial intelligence and others to solve problems in the medical setting.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4889 has been successfully added to your 